Metrics
Emeritus Research has participated in over 100 international clinical trials incorporating Phase 1, Phase II, Phase III and Phase IV.
The success rate on reaching recruitment target = approximately 90%. Those studies where the recruitment target has not been reached have generally been studies that have been difficult to recruit for world-wide, where the northern hemisphere has started earlier, where recruitment has closed early or where the sponsor has delayed the study start.
On many occasions Emeritus Research has been the highest recruiting site in Australia and on at least three occasions the highest recruiting site globally.
You can view our metrics for current studies or metrics for archived studies
Recruiting For Studies
Emeritus Research is currently recruiting for the following studies.
- Orthopaedics, sponsored by Mesoblast Inc
- Psoriatic Arthritis, sponsored by Janssen Cilag
- Rheumatoid Arthritis, sponsored by Roche
- Rheumatoid Arthritis, sponsored by Eli Lilly
- Systemic Lupus Erythematosus, sponsored by Eli Lilly
- Rheumatoid Arthritis, sponsored by Bristol-Myers Squibb
- Sciatica, sponsored by Cephalon
- Systemic Lupus Erythematosus, sponsored by UCB
- Psoriasis, sponsored by Pfizer
- Orthopaedics, sponsored by Eli Lilly
- Smoking Cessation, sponsored by Pfizer
- Device, sponsored by Abbott
- Rheumatoid Arthritis, sponsored by Investigator Initiated
- Low Back Pain, sponsored by Abbott
- Polymyalgia Rheumatica, sponsored by Novartis
- Influenza Vaccine, sponsored by Sanofi Pasteur
- Influenza Vaccine, sponsored by Novavax
- Dupuytren's Contracture, sponsored by Auxilium
- Varicella Zoster Virus Vaccine, sponsored by Merck Sharp & Dohme
- Gout, sponsored by Novotech
Please contact us for further information.
